NAPRELAN (naproxen sodium) by Lavipharm is analgesic, anti-inflammatory, and antipyretic properties. First approved in 1996.
Drug data last refreshed 18h ago · AI intelligence enriched 6d ago
NAPRELAN (naproxen sodium) is an oral extended-release nonsteroidal anti-inflammatory drug (NSAID) approved in 1996 for pain relief, inflammation reduction, and fever management. It works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes to reduce prostaglandin synthesis, thereby decreasing pain signals and inflammatory mediators. Patients with chronic pain conditions, arthritis, and other inflammatory disorders are the primary users.
Declining revenue and minimal claims volume indicate a mature, declining brand with small commercial footprint and limited career growth potential.
analgesic, anti-inflammatory, and antipyretic properties. The mechanism of action of naproxen sodium, like that of other NSAIDs, is not completely understood but involves inhibition of cyclooxygenase (COX-1 and COX-2). Naproxen sodium is a potent inhibitor of prostaglandin synthesis in vitro .…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Multiple-Dose Safety Study of Fixed Combination of Acetaminophen/Naproxen Sodium in Adolescents With Orthodontic Pain
A Study of Acetaminophen/Naproxen Sodium Fixed Combination Tablets in Adolescents 12 to <17 Years of Age With Pain
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
A Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen and Naproxen Sodium in Postoperative Dental Pain
A Study to Learn How Well a Single Dose of the Study Treatment Naproxen Sodium and Caffeine Combined in One Tablet (Fixed-dose Combination) Works to Relieve Pain After Dental Surgeries Compared to the Single Ingredients and to Placebo
Worked on NAPRELAN at Lavipharm? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on NAPRELAN offers limited career advancement given the product's mature, declining lifecycle and minimal linked job count. Roles would focus on defensive commercialization, cost management, and market maintenance rather than innovation or growth.